Skip to Main Content

Paper Details

First Report of Sorafenib in Patients With Acute Myeloid Leukemia Harboring Non-Canonical <i>FLT3</i> Mutations.
Front Oncol
5
2020
Acute Myeloid Leukemia, D835, FLT3, FLT3 Mutations, ITD, Patients, Sorafenib, acute myeloid leukemia, non-canonical FLT3, patient, patients, tyrosine, tyrosine kinase
Author NameAffiliation
Wei ZhangMD Anderson Cancer Center
Wei ZhangMD Anderson Cancer Center
Gautam BorthakurMD Anderson Cancer Center
  • 1 - 3

Datasets

Release 1.2